网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
CT平扫及增强影像组学在急性胰腺炎严重程度评估中的应用研究
作者:李艳霞1 2  蒋圣哲3  陈强1  罗琳1 
单位:1. 内蒙古科技大学包头医学院第一附属医院 医学影像科, 内蒙古 包头 014010;
2. 包头市第六医院 影像科, 内蒙古 包头 014010;
3. 呼伦贝尔市人民医院 影像科, 内蒙古 海拉尔 021000
关键词:急性胰腺炎 CT影像组学 纹理特征 Logistic回归 
分类号:R576;R445.3
出版年·卷·期(页码):2025·53·第三期(356-361)
摘要:

目的: 通过CT平扫及增强影像图像构建影像组学特征,评估急性胰腺炎(AP)患者病情严重性及其发展趋势,以预测AP的严重程度,为AP的临床管理提供一种新的工具。方法: 回顾性收集2018年1月至2024年5月包头医学院第一附属医院CT平扫以及增强扫描AP患者159例。将患者按73比例随机分配至两组,其中训练组为110例患者,验证组为49例患者。使用3D Slicer软件对胰腺整体区域进行逐层准确勾画,从中提取关键的纹理特征。通过数据集的标准化处理、单因素变量分析结合LASSO降维技术以及10折交叉验证法挑选出最佳特征,利用Logistic回归分析,独立构建不同阶段的影像组学模型,包括平扫期、动脉期、静脉期、延迟期、动静脉联合期、增强三期联合模型。通过受试者工作特征曲线下面积(AUC)值来评估其在判断AP严重程度的预测能力。结果: 在训练组中,平扫期、动脉期、静脉期、延迟期、动静脉联合期、增强三期联合模型的AUC分别为0.898、0.867、0.847、0.892、0.890、0.893;在验证组中,平扫期、动脉期、静脉期、延迟期、动静脉联合期、增强三期联合模型的AUC分别为0.749、0.868、0.794、0.806、0.766、0.802。结论: 增强三期联合模型的预测效能高于平扫期、动脉期、静脉期、延迟期及动静脉联合期模型,说明增强三期联合模型在AP患者的严重程度预测方面,具有潜在的临床应用价值。

Objective: To construct imaging features through computed tomography CT plain scans and enhanced images to assess the severity and progression of acute pancreatitis(AP) patients, aiming to predict the severity of AP and provide a new tool for the clinical management of AP. Methods: 159 AP patients were retrospectively collected from January 2018 to May 2024 at the First Affiliated Hospital of Baotou Medical College, including plain scans and enhanced CT scans. Patients were randomly assigned to two groups in a 7 3 ratio, with the training group comprising 110 patients and the validation group comprising 49 patients. The entire pancreatic region was accurately delineated layer by layer using 3D Slicer software to extract key texture features. The best features were selected through standardization of the dataset, univariate analysis combined with LASSO dimensionality reduction, and 10-fold cross-validation. Logistic regression analysis was used to independently construct different stages of the radiomic model, including the plain scan phase, arterial phase, venous phase, delayed phase, combined arterial and venous phase, and the enhanced three-phase combined model. The predictive ability in determining the severity of AP was evaluated through the area under the curve(AUC) value. Results: In the training group, the AUC values for the plain scan phase, arterial phase, venous phase, delayed phase, combined arterial and venous phase, and enhanced three-phase combined model were 0.898, 0.867, 0.847, 0.892, 0.890, and 0.893, respectively; in the validation group, the AUC values were 0.749, 0.868, 0.794, 0.806, 0.766, and 0.802, respectively. Conclusion: The predict effectiveness of enhanced three-phase combined model outperformed the plain scan phase, aterial phase, venous phase, delayed phase, and combined arterial and venous phase models, indicating that the enhanced three-phase combined model has potential clinical application value in predicting the severity of AP patients.

参考文献:

[1] XIAO A Y,TAN M L Y,WU L M,et al.Global incidence and mortality of pancreatic diseases:a systematic review,Meta-analysis,and Meta regression of population-based cohort studies[J].Lancet Gastroenterol Hepatol,2016,1(1):45-55.
[2] MEDEROS M A,REBER H A,GIRGIS M D.Acute pancreatitis:a review[J].JAMA,2021,325(4):382-390.
[3] BOXHOORN L,VOERMANS R P,BOUWENSE S A,et al.Acute pancreatitis[J].Lancet,2020,396(10252):726-734.
[4] SCHEPERS N J,BAKKER O J,BESSELINK M G,et al.Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis[J].Gut,2019,68(6):1044-1051.
[5] HINES O J,PANDOL S J.Management of severe acute pancreatitis[J].BMJ,2019,367:l6227.
[6] PARA O,CARUSO L,SAVO M T,et al.The challenge of prognostic markers in acute pancreatitis:internist's point of view[J].J Genet Eng Biotechnol,2021,19(1):77.
[7] KUMAR A H,GRIWAN M S.A comparison of APACHE Ⅱ,BISAP,Ranson's score and modified CTSI in predicting the severity of acute pancreatitis based on the 2012 revised Atlanta classification[J].Gastroenterol Rep(Oxf),2018,6(2):127-131.
[8] MIKÓ A,VIGH É,MÁTRAI P,et al.Computed tomography severity index vs. other indices in the prediction of severity and mortality in acute pancreatitis:a predictive accuracy Meta-analysis[J].Front Physiol,2019,10:1002.
[9] RAGHUWANSHI S,GUPTA R,VYAS M M,et al.CT evaluation of acute pancreatitis and its prognostic correlation with CT severity index[J].J Clin Diagn Res,2016,10(6):TC06-TC11.
[10] LAMBIN P,LEIJENAAR R T H,DEIST T M,et al.Radiomics:the bridge between medical imaging and personalized medicine[J].Nat Rev Clin Oncol,2017,14(12):749-762.
[11] 张海燕,肖华.胰腺癌术后胰瘘风险预测模型构建及验证[J].现代医学,2024,52(7):1038-1043.
[12] 李晶晶,胡莉钧,黎玉莹,等.CT影像组学在预测宫颈癌同步放化疗临床转归中的价值[J].东南大学学报(医学版),2024,43(3):416-422.
[13] 郭喆,关键.重症急性胰腺炎预防与阻断急诊专家共识[J].临床急诊杂志,2022,23(7):451-462.
[14] SAHU B,ABBEY P,ANAND R,et al.Severity assessment of acute pancreatitis using CT severity index and modified CT severity index:correlation with clinical outcomes and severity grading as per the revised Atlanta classification[J].Indian J Radiol Imaging,2017,27(2):152-160.
[15] SHAFIQ-UI-HASSAN M,ZHANG G G,LATIFI K,et al.Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels[J].Medical Physics,2017,44(3):1050-1062.
[16] 胡云涛,黄小华,刘念,等.基于磁共振 T2WI 序列影像组学预测急性胰腺炎复发的价值[J].磁共振成像,2021,12(10):12-15,21.
[17] LIN Q,JI Y F,CHEN Y,et al.Radiomics model of contrast-enhanced MRI for early prediction of acute pancreatitis severity[J].J Magn Reson Imaging,2020,51(2):397-406.
[18] 陈钰莹,黄小华,唐玲玲,等.增强CT影像组学评估胆源性急性胰腺炎严重程度的应用价值[J].中国医学计算机成像杂志,2023,29(2):161-166.
[19] ZHOU Y,HAN F,SHI X L,et al.Prediction of the severity of acute pancreatitis using machine learning models[J].Postgrad Med,2022,134(7):703-710.
[20] SHIM K Y,CHUNG S W,JEONG J H,et al.Radiomics-based neural network predicts recurrence patterns in glioblastoma using dynamic susceptibility contrast-enhanced MRI[J].Sci Rep,2021,11(1):9974.
[21] YANMEI Z,JIAYI W,BO X,et al.Early prediction of acute pancreatitis severity based on changes in pancreatic and peripancreatic computed tomography radiomics nomogram[J].Quant Imaging Med Surg,2023,13(3):1927-1936.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 885739 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

本系统由北京博渊星辰网络科技有限公司设计开发 技术支持电话:010-63361626

苏ICP备09058541